0.0210
0.0000
(0.00%)
At close: January 22 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,340,148.0000
1,340,148.0000
134,011.0000
74,986.0000
15,486,625.0000
Cost of Revenue
1,391,359.0000
1,391,359.0000
227,869.0000
245,826.0000
12,696,325.0000
Gross Profit
-51,211.0000
-51,211.0000
-93,858.0000
-170,840.0000
2,790,300.0000
Operating Expense
3,628,513.0000
3,628,513.0000
3,526,738.0000
10,648,104.0000
6,232,705.0000
Operating Income
-3,679,724.0000
-3,679,724.0000
-3,620,596.0000
-10,818,944.0000
-3,442,405.0000
Net Non Operating Interest Income Expense
-1,916,674.0000
-1,916,674.0000
-1,222,810.0000
-1,788,377.0000
-2,695,131.0000
Pretax Income
-10,951,918.0000
-10,951,918.0000
-15,783,985.0000
-28,015,749.0000
-7,395,263.0000
Tax Provision
-17,737.0000
-17,737.0000
-931,048.0000
-725,560.0000
269,644.0000
Net Income Common Stockholders
-11,934,199.0000
-11,934,199.0000
-27,660,362.0000
-56,274,540.0000
-7,394,075.0000
Diluted NI Available to Com Stockholders
-11,934,199.0000
-11,934,199.0000
-27,660,362.0000
-56,274,540.0000
-7,394,075.0000
Basic EPS
-1.95
-1.10
-2.55
-5.85
-0.85
Diluted EPS
-1.95
-1.10
-2.55
-5.85
-0.85
Basic Average Shares
10,843,793.0000
10,843,793.0000
10,843,793.0000
9,614,331.0000
8,688,378.0000
Diluted Average Shares
10,843,793.0000
10,843,793.0000
10,843,793.0000
9,614,331.0000
8,688,378.0000
Total Operating Income as Reported
-8,962,165.0000
-8,962,165.0000
-12,141,468.0000
-24,844,989.0000
-4,613,258.0000
Total Expenses
5,019,872.0000
5,019,872.0000
3,754,607.0000
10,893,930.0000
18,929,030.0000
Net Income from Continuing & Discontinued Operation
-11,934,199.0000
-11,934,199.0000
-27,660,362.0000
-56,274,540.0000
-7,394,075.0000
Normalized Income
-5,148,402.6555
-5,148,402.6555
-4,374,416.3662
-12,968,083.8058
-6,494,091.5000
Interest Income
4,598.0000
4,598.0000
8,112.0000
21,649.0000
146,351.0000
Interest Expense
1,921,272.0000
1,921,272.0000
1,230,922.0000
1,810,026.0000
2,841,482.0000
Net Interest Income
-1,916,674.0000
-1,916,674.0000
-1,222,810.0000
-1,788,377.0000
-2,695,131.0000
EBIT
-9,030,646.0000
-9,030,646.0000
-14,553,063.0000
-26,205,723.0000
-4,553,781.0000
EBITDA
-7,897,967.0000
-7,897,967.0000
-13,363,990.0000
-24,398,765.0000
-3,471,457.0000
Reconciled Cost of Revenue
1,391,359.0000
1,391,359.0000
227,869.0000
245,826.0000
12,696,325.0000
Reconciled Depreciation
1,132,679.0000
1,132,679.0000
1,189,073.0000
1,806,958.0000
1,082,324.0000
Net Income from Continuing Operation Net Minority Interest
-10,873,270.0000
-10,873,270.0000
-14,849,590.0000
-27,220,351.0000
-7,394,075.0000
Total Unusual Items Excluding Goodwill
-5,734,154.0000
-5,734,154.0000
-11,131,804.0000
-14,631,190.0000
-1,199,978.0000
Total Unusual Items
-5,734,154.0000
-5,734,154.0000
-11,131,804.0000
-14,631,190.0000
-1,199,978.0000
Normalized EBITDA
-2,163,813.0000
-2,163,813.0000
-2,232,186.0000
-9,767,575.0000
-2,271,479.0000
Tax Rate for Calcs
0.0000
0.0000
0.0001
0.0000
0.0003
Tax Effect of Unusual Items
-9,286.6555
-9,286.6555
-656,630.3662
-378,922.8058
-299,994.5000
12/31/2020 - 2/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6MA.F Ambea AB (publ)
8.09
+1.19%
2LS.F PT Siloam International Hospitals Tbk
0.1650
0.00%
KO2.SG Korian SA
2.1800
-0.73%
ORP2.VI Orpea SA
5.72
-2.36%
SILO.JK PT Siloam International Hospitals Tbk
2,940.00
-0.34%
DANE.TA Danel (Adir Yeoshua) Ltd
43,060.00
-0.51%
MCOV-B.ST Medicover AB (publ)
203.00
-0.98%
EMEIS.PA EMEIS
5.61
-4.38%
OCA.NZ Oceania Healthcare Limited
0.7900
-1.25%
KNB.L Kanabo Group Plc
0.8500
-10.53%